Boston Scientific Stock (BSX) Plunges After Global Cybersecurity Incident
Shares in medical technology group Boston Scientific ($BSX) dipped over 3% in pre-market trading after it revealed it had been hit by a major cyber...
Abbott Laboratories (ABT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 10,897,178 | $988,809,932 | +98% | 0.44% |
| 2. | Citadel Investment Group Ken Griffin | 8,597,227 | $780,112,378 | +349% | 0.09% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 5,542,438 | $502,920,825 | +176% | 0.4% |
| 4. | Diamond Hill Capital Ric Dillon | 4,936,774 | $447,962,873 | -9% | 3.59% |
| 5. | AQR Capital Management Cliff Asness | 4,193,058 | $380,478,062 | +167% | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $86.82 | 2,000 | $173,640.00 | 23,319 | 2026-05-07 | Filing | |
| $92.65 | 10,000 | $926,537.00 | 6,751,103 | 2026-04-27 | Filing | |
| $91.50 | 2,200 | $201,300.00 | 2,200 | 2026-04-23 | Filing | |
| $108.33 | 5,033 | $545,238.98 | 6,738,817 | 2026-02-04 | Filing | |
| $109.14 | 4,967 | $542,092.42 | 6,733,784 | 2026-02-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $109.54 | 27 | $2,957.58 | 24,549 | 2026-09-02 | Filing | |
| $116.19 | 180,297 | $20,948,708.43 | 306,461 | 2026-08-25 | Filing | |
| $115.57 | 218,535 | $25,256,089.95 | 486,758 | 2026-08-25 | Filing | |
| $109.83 | 5,850 | $642,505.50 | 70,724 | 2026-08-11 | Filing | |
| $115.58 | 709 | $81,946.22 | 39,164 | 2026-03-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 152,563,476 | $13,843,609,746 | 0.21% | |
| 2. | 113,750,994 | $10,321,765,196 | 0.22% | |
| 3. | 80,926,234 | $7,343,246,473 | 0.22% | |
| 4. | 59,674,507 | $5,414,865,564 | 0.72% | |
| 5. | 49,017,866 | $4,447,881,161 | 0.2% |
News See All
Pfizer vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?
Pfizer Inc. (NYSE:PFE) and Abbott Laboratories (NYSE:ABT) offer investors two very different dividend stories.
Abbott Pays $670 Million to Settle Formula Claims as Legal Risks Persist
Abbott Laboratories (NYSE:ABT) has agreed to pay $670 million to settle claims involving about 2,000 people who alleged that its specialized preterm infant formulas contributed to necrotizing enterocolitis...
Abbott vs. Intuitive Surgical: Which MedTech Stock Offers Better Long-Term Upside?
MedTech investors are facing an increasingly difficult choice.
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?
Healthcare investors are often faced with a choice between companies that generate steady growth across diversified businesses and those positioned to benefit from improving industry conditions.
Can Abbott Laboratories (ABT)’s Instinct Sensor Give MiniMed Group (MMED) a Competitive Edge?
Two healthcare innovators, MiniMed Group, Inc. (NASDAQ:MMED) and Abbott Laboratories (NYSE:ABT), hit the spotlight this August with a milestone partnership.
Abbott vs. Intuitive Surgical: Is Consistent Growth Better Than Premium Growth?
Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices...
Can Abbott Laboratories (ABT)’s Lingo Partnership With Alphabet (GOOG) Unlock a New Era of AI-Powered Health?
On August 11, medtech leader Abbott Laboratories (NYSE:ABT) and tech behemoth Alphabet Inc. (NASDAQ:GOOG) announced a multi-year partnership to unite continuous glucose monitoring with consumer AI.
Strong Buy Case for Abbott Laboratories (ABT)
Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the “Insiders Fund”. A copy of the letter is available to download here.
SCHD vs. VYMI vs. VIG: Which Is the Best Dividend ETF for Passive Income Investors?
A steady passive income stream means balancing current yield, dividend growth, and geographic exposure. Among the many dividend ETFs available, Sch...
Hedge Fund Resource Center